More interestingly, Vettori et al., when studying the serum levels of factors involved in endothelial, T-cell, and fibroblast interplay in SSc patients, found that IL-33 was significantly higher in early SSc patients, as compared to both controls and SSc patients with a definite disease. The gene discussed is IL33; the disease is systemic sclerosis.